These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12755799)

  • 1. Autoimmune cytopenias in the 22q11.2 deletion syndrome.
    Davies JK; Telfer P; Cavenagh JD; Foot N; Neat M
    Clin Lab Haematol; 2003 Jun; 25(3):195-7. PubMed ID: 12755799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent immune cytopenias in two patients with DiGeorge/velocardiofacial syndrome.
    DePiero AD; Lourie EM; Berman BW; Robin NH; Zinn AB; Hostoffer RW
    J Pediatr; 1997 Sep; 131(3):484-6. PubMed ID: 9329436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evans syndrome in a patient with chromosome 22q11.2 deletion syndrome: a case report.
    Kratz CP; Niehues T; Lyding S; Heusch A; Janssen G; Göbel U
    Pediatr Hematol Oncol; 2003 Mar; 20(2):167-72. PubMed ID: 12554529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auto-immune pancytopenia in a child with DiGeorge syndrome.
    Bruno B; Barbier C; Lambilliotte A; Rey C; Turck D
    Eur J Pediatr; 2002 Jul; 161(7):390-2. PubMed ID: 12111192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes).
    Perez E; Sullivan KE
    Curr Opin Pediatr; 2002 Dec; 14(6):678-83. PubMed ID: 12436034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DiGeorge syndrome/velocardiofacial syndrome: the chromosome 22q11.2 deletion syndrome.
    Sullivan KE
    Adv Exp Med Biol; 2007; 601():37-49. PubMed ID: 17712990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
    Jawad AF; McDonald-Mcginn DM; Zackai E; Sullivan KE
    J Pediatr; 2001 Nov; 139(5):715-23. PubMed ID: 11713452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phenotypic spectrum of the 10p deletion syndrome versus the classical DiGeorge syndrome.
    Van Esch H; Groenen P; Fryns JP; Van de Ven W; Devriendt K
    Genet Couns; 1999; 10(1):59-65. PubMed ID: 10191430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of DiGeorge syndrome: prenatal detection by FISH of a molecular 22q11 deletion.
    Van Hemel JO; Schaap C; Van Opstal D; Mulder MP; Niermeijer MF; Meijers JH
    J Med Genet; 1995 Aug; 32(8):657-8. PubMed ID: 7473663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Philadelphia story: the 22q11.2 deletion: report on 250 patients.
    McDonald-McGinn DM; Kirschner R; Goldmuntz E; Sullivan K; Eicher P; Gerdes M; Moss E; Solot C; Wang P; Jacobs I; Handler S; Knightly C; Heher K; Wilson M; Ming JE; Grace K; Driscoll D; Pasquariello P; Randall P; Larossa D; Emanuel BS; Zackai EH
    Genet Couns; 1999; 10(1):11-24. PubMed ID: 10191425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Features in Patients With 22q11.2 Deletion Syndrome Ascertained by Palatal Abnormalities.
    Vieira TP; Monteiro FP; Sgardioli IC; Souza J; Fett-Conte AC; Monlleó IL; Fontes MB; Félix TM; Leal GF; Ribeiro EM; Gil-da-Silva-Lopes VL
    Cleft Palate Craniofac J; 2015 Jul; 52(4):411-6. PubMed ID: 24805874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FISH investigation of 22q11.2 deletion in patients with immunodeficiency and/or cardiac abnormalities.
    Yakut T; Kilic SS; Cil E; Yapici E; Egeli U
    Pediatr Surg Int; 2006 Apr; 22(4):380-3. PubMed ID: 16463032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient effect of anti-CD20 therapy in a child with 22q11.2 deletion syndrome and severe steroid refractory cytopenias: a case report.
    Soldatou A; Anastassiou T; Vougiouka O; Goussetis E; Kossiva L
    J Pediatr Hematol Oncol; 2013 May; 35(4):311-4. PubMed ID: 23612383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uveitis in DiGeorge syndrome: a case of autoimmune ocular inflammation in a patient with deletion 22q11.2.
    Gottlieb C; Li Z; Uzel G; Nussenblatt RB; Sen HN
    Ophthalmic Genet; 2010 Mar; 31(1):24-9. PubMed ID: 20141355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 22q11.2 deletion syndrome: more answers but more questions.
    Fernhoff PM
    J Pediatr; 2000 Aug; 137(2):145-7. PubMed ID: 10931401
    [No Abstract]   [Full Text] [Related]  

  • 16. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome.
    Sullivan KE
    Immunol Allergy Clin North Am; 2008 May; 28(2):353-66. PubMed ID: 18424337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves' disease in DiGeorge syndrome: patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion.
    Brown JJ; Datta V; Browning MJ; Swift PG
    J Pediatr Endocrinol Metab; 2004 Nov; 17(11):1575-9. PubMed ID: 15570997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic and clinical characteristics of 22q11.2 deletion syndrome].
    Kozlova IuO; Zabnenkova VV; Shilova NV; Min'zhenkova ME; Antonenko VG; Kotlukova NP; Simonova LV; Kazanceva IA; Levchenko EG; Bombardirova TD; Zolotukhina TV; Poliakov AV
    Genetika; 2014 May; 50(5):602-10. PubMed ID: 25715476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis and molecular cytogenetic characterization of chromosome 22q11.2 deletion syndrome associated with congenital heart defects.
    Kuo YL; Chen CP; Wang LK; Ko TM; Chang TY; Chern SR; Wu PS; Chen YT; Chang SY
    Taiwan J Obstet Gynecol; 2014 Jun; 53(2):248-51. PubMed ID: 25017279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transient neonatal hypocalcemia. Onset Manifestation of the 22q11.2 deletion syndrome].
    Pusceddu M; Bertone A; Campra D; Pontoriero D; Guala A
    Minerva Pediatr; 2002 Aug; 54(4):343-5. PubMed ID: 12131871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.